JMP Securities
http://www.jmpsecurities.com/index.htmlJMP Securities provides investment banking services, institutional brokerage, and equity research to public and private growth companies. Equity research is the backbone of the firm and the industries the firm covers are: Business Services, Financial Services, Real Estate, Consumer, Healthcare, and Technology. The firm is headquartered in San Francisco, CA and is a subsidiary of JMP Group (NYSE: JMP).
-
Strongbridge Biopharma (SBBP) PT Lowered to $7 at JMP Securities
-
Strongbridge Biopharma plc to Present at the 2019 JMP Securities Life Sciences Conference
-
Strongbridge Biopharma (SBBP) Announces 9M Proposed Public Offering of Ordinary Shares
-
Strongbridge Biopharma plc Announces Proposed Public Offering of Ordinary Shares
-
Strongbridge Biopharma plc Announces Proposed Public Offering of Ordinary Shares
-
Strongbridge Biopharma (SBBP) PT Raised to $16 at JMP Securities
-
Strongbridge Biopharma plc to Present at the JMP Securities Life Sciences Conference
-
Strongbridge Biopharma plc Announces Underwriters’ Partial Exercise of Option to Purchase Additional Shares
-
Strongbridge Biopharma (SBBP) Prices 5M Offering of Ordinary Shares at $6.75/Share
-
Strongbridge Biopharma plc Announces Pricing of Public Offering of Ordinary Shares
-
Strongbridge Biopharma (SBBP) Plans Offering of 5M Ordinary Shares
-
Strongbridge Biopharma plc Announces Proposed Public Offering of 5 Million Ordinary Shares
-
Strongbridge Biopharma plc to Participate in the JMP Securities Life Science Conference
-
JMP Securities Reiterates Market Outperform on Strongbridge Biopharma (SBBP) Following Acquisition of Keveyis Rights
-
Strongbridge Biopharma (SBBP) Enters $35M Securities Purchase Agreement
-
Strongbridge Biopharma plc Announces $35 Million Equity Financing
-
Strongbridge Biopharma plc to Participate in the JMP Securities Life Sciences Conference and 3rd Annual ROTH Healthcare Day in London
-
JMP Securities Starts Strongbridge Biopharma (SBBP) at Market Outperform
-
Strongbridge Biopharma plc Announces Closing of Initial U.S. Public Offering
-
Strongbridge Biopharma (SBBP) IPO Opens Up 30%
-
Strongbridge Biopharma (SBBP) Sees IPO Offering Size of 4.25M Shares

